These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8657397)

  • 1. Clinical uses of antiestrogens.
    Baker VL; Jaffe RB
    Obstet Gynecol Surv; 1996 Jan; 51(1):45-59. PubMed ID: 8657397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of new pure antiestrogens in clinical breast cancer.
    Wakeling AE
    Breast Cancer Res Treat; 1993; 25(1):1-9. PubMed ID: 8518404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogens in the treatment of breast cancer.
    Legha SS; Carter SK
    Cancer Treat Rev; 1976 Dec; 3(4):205-16. PubMed ID: 1016976
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiestrogens: mechanism of action and clinical applications].
    Barrón-González A; Arias-Martínez J; Castro-Romero I
    Salud Publica Mex; 2001; 43(6):577-84. PubMed ID: 11816234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogens in treatment of breast cancer.
    Tagnon HJ
    Cancer; 1977 Jun; 39(6 Suppl):2959-64. PubMed ID: 326387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiogenesis by antiestrogens.
    Gagliardi A; Collins DC
    Cancer Res; 1993 Feb; 53(3):533-5. PubMed ID: 7678775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.
    Poulin R; Merand Y; Poirier D; Levesque C; Dufour JM; Labrie F
    Breast Cancer Res Treat; 1989 Oct; 14(1):65-76. PubMed ID: 2605344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analyses of mechanistic differences among antiestrogens.
    Wijayaratne AL; Nagel SC; Paige LA; Christensen DJ; Norris JD; Fowlkes DM; McDonnell DP
    Endocrinology; 1999 Dec; 140(12):5828-40. PubMed ID: 10579349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure antiestrogens and breast cancer.
    Elkak AE; Mokbel K
    Curr Med Res Opin; 2001; 17(4):282-9. PubMed ID: 11922402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen.
    Howell A; Osborne CK; Morris C; Wakeling AE
    Cancer; 2000 Aug; 89(4):817-25. PubMed ID: 10951345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
    Lee ES; Schafer JM; Yao K; England G; O'Regan RM; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2000 Dec; 6(12):4893-9. PubMed ID: 11156249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiestrogens in gynecology].
    Laatikainen T
    Duodecim; 1991; 107(6):414-21. PubMed ID: 1364887
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogens: future prospects.
    Howell A
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):59-64. PubMed ID: 9065930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer.
    Katzenellenbogen BS; Montano MM; Ekena K; Herman ME; McInerney EM
    Breast Cancer Res Treat; 1997 May; 44(1):23-38. PubMed ID: 9164675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure antiestrogens as a new therapy for breast cancer.
    England GM; Jordan VC
    Oncol Res; 1997; 9(8):397-402. PubMed ID: 9436192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.